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Abstract 
 
Sepsis is recognised as a global health concern and has a high morbidity and mortality and 
evidence shows that it can be significantly reduced by up to 50% through early recognition 
and treatment. However, indiscriminate antibiotic use can lead to resistant microbial 
strains, and increased cost. Sepsis is newly redefined as life-threatening organ dysfunction 
caused by a dysregulated host response to infection. The red flag features of sepsis by NICE 
is a recommended screening tool. Current biomarkers do not reliably differentiate beween 
sepsis and inflammation, and show a delayed response (12-24 hours) to bacterial infection. 
Evolving research shows procalcitonin is a biomarker released in response to inflammatory 
stimuli during bacterial infections, with very high levels produced in sepsis and enables real-
time monitoring.  This review discusses the new definitions of sepsis, importance of making 
an early diagnosis with appropriate investigations and future diagnostic advancements. 
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'Early diagnosis of severe infection’ 
 
The Surviving Sepsis campaign has increased clinician and public awareness of sepsis and 
the need for early recognition of this medical emergency. In May 2017, the World Health 
Organisation passed a resolution to improve the prevention, diagnosis and treatment of 
sepsis. Sepsis remains a prevalent and problematic global health concern with 30 million 
people affected per year which results in 6-9 million deaths a year and long-term morbidity. 
Data from the United States of America reflects a worldwide trend that the incidence is 
rising by 8% annually. Within the UK, the estimated incidence of sepsis is 147,000 cases per 
year, and the estimated costs of sepsis are £7.76 billion per year, including approximately 
£830 million of direct costs.   
 
Defining the terminology used in sepsis 
 
Infection is common, especially in childhood due to the developing immune system, and can 
be due to viral, bacterial, fungal or parasitic microorganisms. Frequently, it is localised, 
causes no or few systemic symptoms and resolves rapidly, which is in contrast to sepsis, a 
systemic and overwhelming infection, which can be catastrophic. Definitions have recently 
changed. Previously, for over 20 years, systemic inflammatory response syndrome SIRS) 
(if 2 or more of 4 criteria were met: heart rate, respiratory rate, temperature and white cell 
count) alongside a presumed or confirmed source of infection, were adequate to diagnose 
sepsis. Severe sepsis was defined as the above accompanied by organ dysfunction; and 
septic shock was defined as sepsis-induced hypotension persisting despite adequate fluid 
resuscitation.  
 
These definitions are no longer used, due to a lack of specificity, overemphasis upon 
inflammation and an improved understanding of the pathophysiology of sepsis. Sepsis is 
now defined as life-threatening organ dysfunction caused by a dysregulated host response 
to infection. This can result in septic shock, which is cardiovascular dysfunction despite fluid 
resuscitation. In adults, it is defined by lactate >4 mmol/L or systolic blood pressure <90 
mmHg unresponsive to fluid challenge. Although these definitions were devised in adults, 
there is no physiological justification to suggest that there is need for alternative definitions 
in children. However, age specific criteria are required to identify the above processes. 
 
Despite its prevalence, sepsis is difficult to diagnose as there is no gold standard test 
available and there is significant biological and clinical heterogeneity in individual patients. 
Therefore, a diagnosis should require all 3 components of i) infection ii) dysregulated host 
response iii) organ dysfunction. In this review, we will first consider the natural history of 
sepsis and pathobiology, screening for sepsis, examine the individual components required 
to make a diagnosis, appropriate investigations and finally address future advancements 
within the field. 
 
Pathophysiology 
 
Although the pathophysiology of sepsis is not fully elucidated, we have a greater 
understanding that early in sepsis there is activation of both pro-inflammatory and anti-
inflammatory responses, with a net early inflammatory response comprising fever, 
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increased metabolism and shock. However, the extent of such features depends upon 
pathogen load and virulence, nutritional status and co-morbidities. Therefore, clinicians 
should be cognisant of certain groups who may be predisposed to sepsis, for example 
neonates or oncology patients (see box 1), whilst displaying less profound features such as 
normothermia and diminished physiological responses e.g. tachycardia. During sepsis, 
protracted upregulation of genes involved in innate immunity and reduced expression of 
genes that control the adaptive immune response have been identified. Nonetheless, 
studies from patients who died of sepsis have shown a profound anti-inflammatory 
response due to downregulation of activation receptors (CD28, MHC), increased 
proportions of T regulatory cells and poverty of pro and anti-inflammatory cytokine gene 
expression. Therefore, in untreated sepsis, it is unclear whether deaths result from 
intractable inflammation-induced organ dysfunction or due to overwhelming pathogen- 
driven damage, facilitated by immunosuppression. Even with gold standard care, mortality 
from sepsis in paediatric ICU populations ranges from 5.8-32%, but if left untreated can 
rapidly lead to death in virtually 100% of cases. 
 
Importance of early diagnosis 
 
Sepsis is a medical emergency and prompt recognition of its features allows timely 
antimicrobial administration and supportive measures. This has been shown to reduce 
mortality in paediatric sepsis and is supported by national guidelines for treatment to 
commence within an hour. Risk of mortality increases with each hour delay from sepsis 
recognition to antimicrobial therapy greater than 3 hours, regardless of initial severity of 
illness. Prompt antimicrobial administration also reduces organ failure days.  
 
Screening 
 
In view of the above, a sepsis screening bundle is recommended by the Surviving Sepsis 
campaign since early diagnosis and intervention improves outcomes. National institute of 
health and care excellence (NICE) guidelines have graded clinical parameters for those at 
high and moderate risk of sepsis, see Table 1. This is useful in community and triage settings 
to identify red flag signs of sepsis for further, urgent referral and management. Within UK 
hospitals, these parameters are being coupled with early warning scores and trigger 
instigation of a comprehensive sepsis bundle based on NICE guidance. 
 
 
Diagnosis 
 
Infection is the first component required to make a diagnosis of sepsis. This is largely 
elucidated from the history and examination. Features may be non-specific in newborns 
such as irritability and poor feeding but in older children for example, increased work of 
breathing and productive cough and chest signs are suggestive of pulmonary infection. 
Localising symptoms can also be seen in meningitis, encephalitis, urinary tract infection, 
peritonitis or cellulitis. Certain features of infection can be relatively non-specific such as 
vomiting and exanthem. However, sources of infection that are more commonly overlooked 
include infective endocarditis and osteomyelitis. 
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There are no clinical tests currently available for dysregulated host response. However, 
certain groups of patients are more susceptible to infection and may have more non-specific 
or subtle evidence of infection: examples are found in Box 1. Specific guidelines should be 
followed for those at risk of early neonatal sepsis and also for neutropenic sepsis. 
 
 
Finally, the infection must cause organ dysfunction and there are a number of tools to 
assess this. Paediatric Logistic Organ Dysfunction (PELOD) or paediatric Sequential Organ 
Failure Assessment (pSOFA- see Table 2) are both highly validated prognostic scores, with 
pSOFA being more widely used and supported in the Sepsis-3 guidelines. SOFA scores are 
adjusted for age appropriate cardiovascular and renal values and alternative SpO2: FiO2 
ratios are added to respiratory parameters. pSOFA scores show excellent discrimination for 
in-hospital mortality on admission or sequentially during admission. A single centre 
retrospective study identified that a score above 8 was the optimal cut-off to discriminate 
mortality, which is identical to the cut off score in adults. Nevertheless, both require 
detailed results that are not available on initial presentation or in most clinical treatment 
settings except intensive care.  
 
Septic shock, is evidence of profound organ dysfunction but in children development of 
arterial hypotension occurs at a later stage than in adults. Previous consensus definitions 
are hyperlactataemia (varies between >2 mmol/L to >8 mmol/L), vaso-inotrope dependency 
or myocardial dysfunction and have not been updated with the publication of Sepsis-3 
guidelines. It should be managed within intensive care facilities as it carries an excess 
mortality risk of 49.7%. 
 
 
Investigations 
 
When severe infection is suspected, appropriate investigations should be taken to identify 
the pathogen, its sensitivities if applicable, and source. NICE guideline NG51, Sepsis: 
recognition, diagnosis and early management, recommends in children that investigations 
should be tailored based upon history and clinical examination. A sterile urine sample 
should be collected for a urine dipstick test in all children over 3 months old and sent for 
microscopy, culture and sensitivity if positive, or if the child is under 3 months, then 
microscopy, culture and sensitivities should be sent in all cases. Blood cultures are 
recommended in children with 1 red flag symptom, alongside haematology, biochemistry 
and coagulation, unless if after senior review an alternative diagnosis is found. If the child 
has coryzal symptoms, nasopharyngeal aspirate is recommended . If there are suggestive 
chest signs, a chest radiograph may be useful in evaluating pneumonia and its sequelae. 
Stool cultures should be obtained if diarrhoea is present. Lumbar puncture is 
recommended, provided there are no contraindications in suspected meningitis or 
encephalitis, in all infants presenting under 1 month and in those 1-3 months old with white 
cell count <5 or >15 x109/L or who appear unwell. Imagining of the abdomen and pelvis is 
recommended if no source is found on examination and after initial test results. 
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Sepsis can be a consequence of bacterial, viral, or fungal infections, therefore, diagnosis 
depends upon the underlying aetiology. Surviving Sepsis campaign recommends 
galactomannan and beta-D-glucan measurements as aspergillus and invasive fungal 
biomarkers. However, there are no other recommended gold standard investigations. White 
cell count may be raised or inappropriately suppressed in sepsis, and neutrophilia rather 
than lymphocytosis may suggest a bacterial cause as opposed to a viral source, but this is 
not very reliable. Equally, minimal increases in C reactive protein (CRP) are more typical of 
viral infection, compared to higher values in bacterial infection but CRP shows a delayed 
response (12-24 hours) to bacterial infection, so may be falesly low in rapid onset life-
threatening sepsis. Lactate is a sensitive biomarker of cellular dysfunction- typically tissue 
hypoperfusion and impaired aerobic respiration. However, it is not specific to sepsis or its 
aetiology, although as discussed earlier it is an important marker of septic shock. 
 
New advancements for the diagnosis of sepsis 
 
Although not currently used in regular clinical practice within the UK, there is a variety of 
biomarkers for bacterial and viral causes of sepsis. Additionally, they are being developed as 
point of care rapid tests that can influence real time, refined clinical decision making. This 
will also reduce unnecessary antimicrobial prescribing and in so, decreasing adverse drug 
reactions and antimicrobial resistance. Procalcitonin is a biomarker of bacterial infection, 
which in contrast to CRP, PCT rises early (within 6-12 hours) and peaks early, falling rapidly 
in response to effective antimicrobial therapy. A multicentre randomized controlled trial in 
neonates found it was safe and effective to reduce the duration of antibiotic treatment in 
early onset sepsis using procalcitonin to guide clinical decisions to stop antibiotics, without 
increasing re-infection or death. There is additional supporting data available for adults but 
no publications for procalcitonin guided paediatric antimicrobial prescribing and duration. 
Procalcitonin can also discriminate between mycobacterial tuberculosis pneumonia and 
other bacterial causes of pulmonary infiltrates, infection versus disease flare in autoimmune 
conditions and invasive fungal infections. Pro-adrenomedullin (pro-ADM) concentration in 
neonatal sepsis are significantly higher at baseline compared to CRP or IL-6. However, in a 
larger study involving children under 36 months with fever, pro-ADM was less sensitive and 
specific than CRP or procalcitonin in diagnosing invasive bacterial infections. Viral 
biomarkers include tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and 
interferon γ-induced protein-10 (IP-10) which are induced by viral infections. Other 
potential biomarkers include soluble receptors and cytokines. Increasingly, biomarker 
panels, such as ImmunoXpert assay for TRAIL, IP-10 and CRP are being show to have high 
sensitivity and specificity for identifying bacterial or viral pathogens in sepsis. 
 
Microbiology offers more promise in confirming diagnosis, but techniques are often slow. 
Viral pathogens may be identified from PCR of nasopharyngeal aspirates or cerebrospinal 
fluid (CSF) in 24 hours. Sputum samples are difficult to obtain in children, and although 
cultures from bronchoscopy have high yields this is an invasive procedure. In paediatrics, 
urine and venous blood samples can be very difficult to obtain practically. Blood cultures 
take 24 hours for initial results but 72 hours for definitive results. Additionally, we do not 
have robust culture methods for certain bacteria like Chlamydia or Borellia spp and yield 
remains low with only 30-40% of total cases being ‘culture positive’ once all microbiological 
tests are completed. Molecular microbiology allows polymerase chain reaction (PCR) of 
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blood or CSF to diagnose the microbe more rapidly than culture techniques . The FilmArray 
system from Biofire has respiratory, meningitis/encephalitis and blood culture panels. Novel 
advancements within spectroscopy are showing promise in this area. With further 
validation, molecular signatures from transcriptomic, metabolomic or proteomic analysis 
will likely lead to faster diagnosis and better characterization of specific population subsets 
for targeted therapies. 
 
Differential diagnoses  
 
The features of sepsis overlap with many other conditions. Some of the most common 
differentials include post immunisation reactions (particularly Men B vaccine), autoimmune 
conditions e.g. SLE or Still’s disease, neoplastic e.g. ALL, vasculitides e.g. Kawasaki’s disease, 
pancreatitis and burns or trauma inflammatory responses. 
 
Conclusion 
 
Sepsis carries a high morbidity and mortality rate and public awareness and healthcare 
bundles have improved in recent years. Careful history taking and examination, alongside 
refined definitions and NICE sepsis red flag symptoms can guide clinicians to diagnose sepsis 
earlier, although this remains a challenge without a gold standard test. Revised definitions 
of sepsis as life-threatening organ dysfunction caused by a dysregulated host response to 
infection, allows more accurate diagnoses with greater specificity. Without a definitive test 
for sepsis, clinicians must satisfy each of the above components but current areas of 
research are showing promise in development of tests. Early diagnosis allows for early 
instatement of antimicrobials, fluids, oxygen and if appropriate, referral to other specialties. 
Sepsis biomarkers with high diagnostic accuracy and predictive value, and which can be 
measured at the bedside should reduce the risks of failing to identify potentially life-
threatening sepsis. 
 
Practice Points 
 
• Sepsis is life-threatening organ dysfunction caused by a dysregulated host response 
to infection. 
• NICE sepsis criteria of high and moderate risk parameters should be used in 
screening to guide referral and investigations. 
• Careful clinical examination can identify the source of infection and pSOFA score 
identifies organ dysfunction. 
• No gold standard test exists to diagnose sepsis but appropriate microbiological 
investigations may yield a diagnosis. 
• Areas of rapid diagnostic development include biomarker panels for procalcitonin , 
CRP , IP-10 and TRAIL  
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High risk Moderate risk 
Abnormal behaviour: 
-no response to social cues 
-does not wake, or if roused does 
not stay awake 
-weak, high-pitched or continuous 
cry 
Unusual behaviour: 
-not responding normally to social cues 
-no smile 
-wakes only with prolonged stimulation 
-decreased activity 
Appears ill to a healthcare 
professional 
Parent or carer concerned that the child is behaving 
differently from usual 
Severe tachycardia according to age Moderate tachycardia according to age 
Severe tachypnoea according to age Moderate tachypnoea according to age 
Grunting, apnoea Nasal flaring 
SpO2 <90% SpO2 <92% 
Cyanosis Pallor 
Non blanching rash Capillary refill time >3s 
Mottling or ashen appearance Cold extremities 
Temperature <36˚C in under 5s Temperature <36˚C in over 5s 
Less than 3 months old and >38˚C Reduced urine output 
Table 1 : NICE guidelines for features to evaluate of the level of risk of sepsis in children. 
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• Children under 1 year of age 
• Patients undergoing chemotherapy (or within past 6 months) 
• Patients undergoing surgery/ invasive procedures within the past 6 weeks 
• Patients with congenital/ acquired immunodeficiency (CVID, HIV, diabetes) 
• Patients on disease modifying agents (IBD, JIA) 
• Patients on long term steroids (asthma) 
• Patients with (functional) asplenia (sickle cell, SLE, splenectomy) 
• Patients with indwelling lines or catheters 
• Patients who use intravenous drugs 
• Patients with a breach to skin barrier function (burns) 
• Neonates: particularly if any of the following: 
– Invasive group B streptococcal infection in a previous baby 
– Maternal group B streptococcal colonisation, bacteriuria, or infection in the 
current pregnancy 
– Prelabour rupture of membranes 
– Preterm birth after spontaneous labour (before 37 weeks’ gestation) 
– Suspected or confirmed rupture of membranes for >18 hours in a preterm birth 
– Maternal intrapartum fever >38°C, or confirmed or suspected chorioamnionitis 
Box 1: Groups of patients who may be at increased risk of sepsis 
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System 0 1 2 3 4 
Respiratory ≥53.3 <53.3 <40 <26.7 with 
respiratory 
support 
< with 
respiratory 
support PaO2: FiO2 
(mmHg) 
SpO2:FiO2 * ≥292 264-
291 
221-264 148-220 with 
respiratory 
support 
<148 with 
respiratory 
support 
Circulatory 
MAP  
(mmHg) or 
vasoactive 
infusion 
(μg/kg/min) 
<1 month ≥46 <46 Dopamine 
≤5 or 
dobutamine 
Dopamine 5.1-
15, 
noradrenaline/ 
adrenaline ≤0.1 
Dopamine >15, 
noradrenaline/ 
adrenaline >0.1 1-
11months 
≥55 <55 
12-23 
months 
≥60 <60 
24-59 
months 
≥62 <62 
60-143m ≥65 <65 
144-216m ≥67 <67 
>216m ≥70 <70 
Coagulation  ≥150 100-
149 
50-99 20-49 <20 
platelets 
(x109/L) 
Liver  <20 20-
32 
33-101 102-204 >204 
bilirubin 
(μmol/L) 
CNS 15 13-
14 
10-12 6-9 <6 
Paediatric 
Glasgow 
Coma score 
Renal <110 110-
170 
171-299 300-440 >440 
creatinine  
(μmol/L) 
urine output 
(mL/d) 
- - - <500 <200 
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Abbreviations: PaO2 arterial partial pressure of oxygen; FiO2, fraction of inspired oxygen; 
SpO2 peripheral oxygen saturation; MAP, mean arterial pressure; m, months old. *Only 
SpO2 measurements of ≤97% were used in the calculation 
 
Table 2: Paediatric Sequential Organ Failure Assessment parameters to score organ 
dysfunction severity. 
 
